Abstract
The transfer of technology for vaccine production is crucial to ensuring the fight against infectious diseases on a global scale. Thus, among the various requirements for this production to be carried out safely, the implementation of quality control stands out, which involves everything from acquiring raw materials and qualifying suppliers to carrying out microbiological and physical-chemical tests. The objective of this work was to demonstrate the purity test used in the quality control of sodium hydroxide, one of the inputs acquired for the production of the RNA MCTI CIMATEC HDT vaccine. The limit of carbonates present in the sample under study was determined as described in the official compendium, obtaining results compatible with current specifications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JOURNAL OF BIOENGINEERING, TECHNOLOGIES AND HEALTH
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
